International Stem Cell Corp. (ISCO.OB) and Absorption Systems’ Experiments Confirm Lab-grown Tissue as Replacement for Animals in Drug Testing
Biotechnology company International Stem Cell Corp. today posted the results of a second set of experiments on lab-grown corneal tissue. The results support previous studies that show the tissue as similar to drug absorption and drug metabolism characteristics found in normal corneal tissue, confirming the potential therapeutic value in treating corneal injury and disease, and suggesting the tissue’s potential as a replacement to animal testing. ISCO's human corneal tissue is created in the laboratories of its wholly owned subsidiary, Lifeline Cell Technology. The company said that additional experiments will be conducted to better define optical characteristics shown in the experiments.…